In vitro activity of titanocenedichloride versus cisplatin and doxorubicin in primary and recurrent epithelial ovarian cancer.

Kurbacher, C M; Mallmann, P; Kurbacher, J A; Sass, G; Andreotti, P E; Rahmun, A; Hübner, H; Krebs, D

Kurbacher, C M; Mallmann, P; Kurbacher, J A; Sass, G; Andreotti, P E; Rahmun, A; Hübner, H; Krebs, D.

Affiliation

Kurbacher CM; Department of Gynecology and Obstetrics, University of Bonn, Germany.

Anticancer Res ; 14(5A): 1961-5, 1994.

Article in En | MEDLINE | ID: mdl-7847834

Subject(s)

Antineoplastic Agents/pharmacology; Cisplatin/pharmacology; Doxorubicin/pharmacology; Organometallic Compounds/pharmacology; Ovarian Neoplasms/drug therapy; Adenosine Triphosphate/analysis; Drug Screening Assays, Antitumor; Epithelium/pathology; Female; Humans; Luminescent Measurements

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Organometallic Compounds / Ovarian Neoplasms / Doxorubicin / Cisplatin / Antineoplastic Agents Limits: Female / Humans Language: En Journal: Anticancer Res Year: 1994 Document type: Article Affiliation country: Germany Country of publication: Greece

Search on Google

Add to My VHL

XML

PubMed Links